(MedPage Today) — WASHINGTON — Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a retrospective cohort study from…
Source link : https://www.medpagetoday.com/meetingcoverage/aasld/118517
Author :
Publish date : 2025-11-13 22:42:00
Copyright for syndicated content belongs to the linked Source.
